"Pertussis Vaccine" - Books

Result Filters

Results: 1 to 20 of 299 books (1378 items)

<< First< Prev

Page of 15

Select item 32654301.

Adverse Effects of Pertussis and Rubella Vaccines: A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines.

Institute of Medicine (US) Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines; Howson CP, Howe CJ, Fineberg HV, editors.

Washington (DC): National Academies Press (US); 1991.

Top results in this book Table of Contents

Select item 30760202.

Adverse Effects of Vaccines: Evidence and Causality.

Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors.

Washington (DC): National Academies Press (US); 2011 Aug 25.

Top results in this book Table of Contents

Select item 44036683.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Top results in this book Table of Contents

Select item 32878924.

Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality.

Institute of Medicine (US) Vaccine Safety Committee; Stratton KR, Howe CJ, Johnston RB Jr, editors.

Washington (DC): National Academies Press (US); 1994.

Top results in this book Table of Contents

Select item 52186005.

Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].

Gidengil C, Goetz MB, Maglione M, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. (Comparative Effectiveness Review, No. 244.)

Top results in this book Table of Contents

Select item 48307566.

Vaccinating Britain: Mass vaccination and the public since the Second World War [Internet].

Millward G.

Manchester (UK): Manchester University Press; 2019.

Top results in this book Table of Contents

Select item 31881147.

Financing Vaccines in the 21st Century: Assuring Access and Availability.

Institute of Medicine (US) Committee on the Evaluation of Vaccine Purchase Financing in the United States.

Washington (DC): National Academies Press (US); 2003.

Top results in this book Table of Contents

Select item 16596948.

Disease Control Priorities in Developing Countries. 2nd edition.

Jamison DT, Breman JG, Measham AR, et al., editors.

Washington (DC): The International Bank for Reconstruction and Development / The World Bank; New York: Oxford University Press; 2006.

Top results in this book Table of Contents

Select item 31534509.

Vaccine Supply and Innovation.

National Research Council (US) Division of Health Promotion and Disease Prevention.

Washington (DC): National Academies Press (US); 1985.

Top results in this book Table of Contents

Select item 328906210.

The Children's Vaccine Initiative: Achieving the Vision.

Institute of Medicine (US) Committee on the Children's Vaccine Initiative: Planning Alternative Strategies; Mitchell VS, Philipose NM, Sanford JP, editors.

Washington (DC): National Academies Press (US); 1993.

Top results in this book Table of Contents

Select item 310354611.

The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies.

Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule; Board on Population Health and Public Health Practice; Institute of Medicine.

Washington (DC): National Academies Press (US); 2013 Mar 27.

Top results in this book Table of Contents

Select item 317312012.

Priorities for the National Vaccine Plan.

Institute of Medicine (US) Committee on Review of Priorities in the National Vaccine Plan.

Washington (DC): National Academies Press (US); 2010.

Top results in this book Table of Contents

Select item 265918213.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 322301214.

DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis.

Institute of Medicine (US) Committee to Study New Research on Vaccines; Stratton KR, Howe CJ, Johnston RB Jr, editors.

Washington (DC): National Academies Press (US); 1994.

Top results in this book Table of Contents

Select item 322631015.

Calling the Shots: Immunization Finance Policies and Practices.

Institute of Medicine (US) Committee on Immunization Finance Policies and Practices.

Washington (DC): National Academies Press (US); 2000.

Top results in this book Table of Contents

Select item 318441616.

Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy.

Institute of Medicine (US) Immunization Safety Review Committee; Stratton K, Almario DA, Wizemann TM, et al., editors.

Washington (DC): National Academies Press (US); 2003.

Top results in this book Table of Contents

Select item 317101417.

New Vaccine Development Establishing Priorities: Volume II: Diseases of Importance in Developing Countries.

Institute of Medicine (US) Committee on Issues and Priorities for New Vaccine Development.

Washington (DC): National Academies Press (US); 1986.

Top results in this book Table of Contents

Select item 425931418.

Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2).

Black RE, Laxminarayan R, Temmerman M, et al., editors.

Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Apr 5.

Top results in this book Table of Contents

Select item 321221619.

Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders.

Institute of Medicine (US) Immunization Safety Review Committee; Stratton K, Gable A, McCormick MC, editors.

Washington (DC): National Academies Press (US); 2001.

Top results in this book Table of Contents

Select item 195848820.

Immunization Safety Review: Vaccines and Autism.

Institute of Medicine (US) Immunization Safety Review Committee.

Washington (DC): National Academies Press (US); 2004.

Top results in this book Table of Contents

<< First< Prev

Page of 15

Next >Last >>

Supplemental Content

Images search in Bookshelf

FIGURE 3-1Zero-dose, underimmunized, and immunized children in Gavi-supported countries (2000–2019)

NOTE: DTP = diphtheria, tetanus, and pertussis vaccine; DTP3 = diphtheria, tetanus, and pertussis vaccine dose 3; m = million.
SOURCE: Gupta presentation, August 17, 2020.

Improving Access and Closing the Global Immunization Gap.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health; Forum on Microbial Threats; Nicholson A, Minicucci C, Liao J, editors. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington (DC): National Academies Press (US); 2021 Apr 29.
Figure 1Summary of the qualitative findings relating to pertussis vaccine uptake in pregnant women

See below and review B for more details.

Evidence review for interventions to increase the uptake of routine vaccines for pregnant women: Vaccine uptake in the general population: Evidence review F.

Evidence review for interventions to increase the uptake of routine vaccines for pregnant women: Vaccine uptake in the general population: Evidence review F. London: National Institute for Health and Care Excellence (NICE); 2022 May.
Figure 12.1

Percentage of Target Population in Africa Vaccinated, by Vaccine Type, 1980–2002
Source: WHO 2003.
Note: BCG = bacillus Calmette-Guérin; DTP3 = three doses of diphtheria, tetanus, pertussis vaccine; HBV = hepatitis B virus; TT = tetanus toxoid; and YF = yellow fever.

Vaccine-Preventable Diseases.

Jamison DT, Feachem RG, Makgoba MW, et al., editors. Disease and Mortality in Sub-Saharan Africa. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2006.
Figure 4Number of studies evaluated for vaccines identified in this update

Notes: Data given for the report update at the time of the draft report. aIIV—Adjuvanted inactivated influenza vaccine; DTaP—Diphtheria, tetanus, and acellular pertussis vaccine; HepA—Hepatitis A vaccine; HepB—Hepatitis B vaccine; HepA-HepB—Hepatitis A and hepatitis B vaccine; Hib— Haemophilus influenzae type b vaccine; HPV9—9-valent human papillomavirus vaccine; IIV—Inactivated influenza vaccine; IPV—inactivated poliovirus vaccine; LAIV—Live attenuated influenza vaccine; MenACWY—Serogroups A, C, W, and Y meningococcal vaccine; MenB—Serogroup B meningococcal vaccine; MMR—Measles, mumps rubella vaccine; MMR-V—Measles, mumps, rubella, and varicella vaccine; PCV13—13-valent pneumococcal conjugate vaccine; PPSV23—23-valent pneumococcal polysaccharide vaccine; RIV—Recombinant influenza vaccine; RV—Rotavirus vaccine; Td—Tetanus, diphtheria vaccine; Tdap—Tetanus, diphtheria, and acellular pertussis vaccine; VAR—Varicella vaccine.

Results.

Gidengil C, Goetz MB, Maglione M, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May.